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Epicardial VT. Background: Epicardial left ventricular (LV) idiopathic ventricular arrhythmias (VAs)
can be approached via the pericardial space, the coronary venous system (CVS), or other surrounding
structures. The anatomic relationships between epicardial sites of origin (SOO) of VAs and surrounding
anatomic structures have not been systematically described.
Methods and Results: In 17 patients with idiopathic epicardial VAs, the relationships between the SOO and
the CVS and other neighboring anatomic structures were assessed by computed tomographic angiography.
Ablation was successful in 12/17 patients (71%). In 10/17 patients, the SOO was at a distance of 4 mm
from a coronary artery. The SOO was closer to the CVS (2.1 ± 1.5 mm) than to the pericardial space (9.7
± 3.7 mm) or the LV endocardium (7.7 ± 2.7 mm). Successful ablations were carried out from the CVS
(n = 3), the CVS and LV endocardium (n = 5), the CVS and the aortic cusp (n = 1), the CVS, the LV
endocardium, and the aortic cusp (n = 1), the LV endocardium (n = 1), and the CVS and the pericardial
space (n = 1). In the remaining 5 patients, a subxyphoid pericardial ablation procedure was attempted and
failed in all 5 patients.
Conclusion: The CVS is closer to the SOO of epicardial idiopathic VAs than the pericardial space, the
ventricular endocardium, and the aortic cusps. Given the proximity to coronary arteries at the SOO,
radiofrequency energy often cannot be safely delivered to eliminate a VA and ablation may also need to be
performed from adjacent structures. A subxyphoid pericardial ablation procedure has a low probability
of success in patients with idiopathic epicardial VAs. (J Cardiovasc Electrophysiol, Vol. 25, pp. 1336-1342,
December 2014)
catheter ablation, coronary venous system, epicardial ablation, idiopathic ventricular tachycardia, ventricular
tachycardia
Background
Idiopathic ventricular arrhythmias (VAs) can arise from
the left ventricular epicardium. Different approaches have
been described for radiofrequency ablation including a sub-
xyphoid pericardial approach,1 an approach via the coronary
venous system (CVS),2 and a combined approach via adja-
cent anatomical structures including the CVS and the ventric-
ular endocardium or the aortic cusps.3 We hypothesized that
the CVS is closer to the epicardial myocardium where VAs
originate from than is the pericardial space. The proximity
of actual and potential ablation sites within the CVS to the
left ventricular epicardium has not been described systemati-
cally. The purpose of this report was to describe the anatomic
relationships at the site of origin (SOO) of epicardial VAs to
the CVS, the pericardial space, the coronary arteries, and
other surrounding structures.
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Methods
Patient Characteristics (Table 1)
The study subjects consisted of 17 consecutive patients
(12 males, age 51 ± 14 years, ejection fraction: 46 ± 12%)
referred for ablation of VAs originating from the epicardium.
Patients were included in this study if they had idiopathic VAs
with an epicardial SOO based on intracardiac mapping. Two
patients had prior myocardial infarctions. The patients had
cardiac magnetic resonance imaging prior to the procedure.
In the 2 patients with prior myocardial infarction, the location
of the scar was not epicardial and did not involve the SOO of
the VAs. The VAs consisted of PVCs in 8 patients and VT in
9 patients. Twelve of 17 patients (71%) had previously failed
ablation procedures. Patients had a mean of 2.4± 3 different
VAs (range 1–11). The predominant VA was epicardial in
origin.
The patients had not responded to a mean of 1.4 ± 1
antiarrhythmic medications. Cardiac-computed tomographic
angiography was performed to evaluate the coronary arteries
and the CVS as well as the anatomic relation to adjacent
structures.
SOO and 12-Lead ECG
Twelve-lead electrocardiograms (ECG) of the VAs were
recorded in all patients. The ECG was analyzed for bundle
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Figure 1. Left panel: Twelve-lead ECG
of a spontaneous VT with a right bundle
branch block morphology. Middle panel:
Local activation time (-27 milliseconds)
at the site of origin within the great car-
diac vein (GCV). Right panel: Pacing in
the distal GCV results in a QRS morphol-
ogy that matches with the QRS morphol-
ogy of the induced VT.
Figure 2. Right anterior oblique view of the left main coronary artery with
its bifurcation into the left anterior descending and circumflex artery. The
ablation catheter and distal recording electrodes are marked with yellow
tags. The ablation catheter is at the site of origin of the ventricular ar-
rhythmia. Bifurcation sites of the coronary artery are marked with red tags
indicating fiducial points that were used for image registration to the CTA
images. For a high quality, full color version of this figure, please see Jour-
nal of Cardiovascular Electrophysiology’s website: www.wileyonlinelibrary.
com/journal/jce
branch block morphology, axis, QRS width, and the pre-
cordial transition (before or after V1). R wave and S wave
width as well as percentage of the R wave relative to the
QRS duration were measured in leads V1 and V2. The
SOO was defined as the earliest activation time obtained
during mapping in the presence of a matching pace-map
(10/12 leads) at this site (Fig. 1). An epicardial SOO was
defined as an early activation time combined with a match-
ing pace-map from within the CVS or the epicardial space.
The epicardial myocardium closest to the location of the
mapping catheter where these criteria were met was de-
fined as the SOO. An epicardial SOO was identified in all
patients.
Electrophysiology Study and Mapping
After informed consent was obtained, several multipolar
catheters were introduced into the femoral veins and posi-
tioned in the His bundle position and the right ventricular
apex. Arterial access was obtained in the femoral artery.
After vascular access was obtained, 3,000 units of heparin
was given and an ACT of >250 seconds was targeted with
additional heparin administration. Programmed stimulation
was repeated during infusion of isoproterenol. Electrograms
were filtered from 50 to 500 Hz. Recordings of the intracar-
diac electrograms were archived on disc (EP Med Systems,
West Berlin, NJ, USA). An electroanatomical mapping sys-
tem (CARTO, Biosense Webster, Diamond Bar, CA, USA)
was used to guide mapping. Activation mapping was per-
formed during VAs: PVCs or VT. Mapping was performed in
the following sequence: For right bundle branch block VAs,
the first anatomic structure that was mapped was the CVS
followed by the aortic cusp, the left ventricular endocardium,
and the right ventricular outflow tract. In patients with a left
bundle branch block VA morphology, mapping was first per-
formed in the right ventricular outflow tract, followed by the
CVS, the aortic cusp, and the left ventricular endocardium.
Pacing was performed (10–20 mA with a pulse width of 2
milliseconds) at the earliest site of activation, and if there was
a matching pace-map, this was defined as the SOO. The coro-
nary arteries were injected while the ablation catheter was
at the SOO. Pacing was performed at high output (20 mA
at 2 milliseconds pulse width) to assess for phrenic nerve
capture. If the distance to the closest coronary artery was
>4 mm,4 radiofrequency energy was applied at a power of
20–30 W using an open irrigated-tip catheter (Thermocool,
Biosense Webster) targeting an impedance drop of 10 Ohms
for 60 seconds. If this eliminated the VA, an additional RF
application of 60 seconds was delivered. If ablation failed to
eliminate the VA, the aortic cusp and the mitral annulus were
mapped. At the site closest to the SOO, pace-mapping was
performed and radiofrequency energy was delivered. If this
failed to eliminate the VA, a subxyphoid pericardial map-
ping procedure was attempted. Coronary angiography was
repeated at the conclusion of the procedure. The successful
site was defined as the target site that eliminated the VA.
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Figure 3. Multiplanar oblique reformatted view (2D) of the CTA at the
level of the bifurcation of the left main coronary artery with the registered
fiducial point from the coronary angiography (Fig. 2). Arrows indicate the
great cardiac vein (GCV), the anterior interventricular vein (AIV), the left
main (LM) coronary artery with its bifurcation (Bif). The left ventricle (LV),
the left atrium (LA), and the aorta (Ao) are also indicated. Location of the
ablation catheter and distal recording electrodes are marked with yellow
tags. For a high quality, full color version of this figure, please see Jour-
nal of Cardiovascular Electrophysiology’s website: www.wileyonlinelibrary.
com/journal/jce
If this occurred in the CVS, the CVS was defined as the
successful site. If this occurred in the left ventricular endo-
cardium after ablation within the CVS had failed, the suc-
cessful site was defined as the CVS and the left ventricular
endocardium.
Cardiac-Computed Tomographic Angiography
All patients underwent an ECG-gated contrast-enhanced
CT angiography (CTA) scan using a 64 slice CT scanner
(Discovery GE 750 HD, GE Healthcare, Milwaukee, WI,
USA). Following a timing bolus with 15 mL of iopamidol
(Isovue, Bracco Imaging, Singen, Germany) nonionic intra-
venous contrast medium at 5 mL/second, a scan delay of peak
plus 6 seconds was used to obtain the dedicated coronary
CTA. Acquisition was performed at end diastole following
an intravenously administered bolus via an antecubital vein
of 80 mL iopamidol nonionic intravenous contrast medium
followed by 50 mL saline at 5 mL/second using a triphasic
bolus power injector (MedRad Stellant MedRad Inc., War-
rendale, PA, USA). In a post hoc analysis, the relationship
between the CVS and neighboring anatomic structures was
assessed. When the catheter was at the SOO, the left coronary
artery was injected and the distance to the closest coronary
artery was determined using biplane angiograms (Fig. 2).
The tip and the distal electrodes of the ablation catheter were
also identified on the 2D angiograms (Fig. 2). The angiogram
with the catheter at the SOO was registered into the coronary
CTA by using arterial bifurcations as fiducial points in end-
diastole (Figs. 2 and 3). Using the locations of these fiducial
markers and the angle between the cameras, 3D coordinates
of the branch points and the catheter were calculated. The
same branching points were located on a 3D CT angiogram
study (Fig. 3). Using customized algorithms (Matlab, The
Mathworks, Natick, MA, USA), the branching points from
the 2D angiograms were translated and rotated by a least-
square minimization routine to align with the branch points
of the 3D CTA study. The position of the catheter was then
translated and rotated by the same procedure to locate the
catheter on the 3D CTA study. The positional error was 3.5
± 2.2 mm. The position of the catheter was visualized by su-
perposition of the catheter points onto the 3D CT angiogram
data (Fig. S1). The location of the catheter tip at the SOO of
the VA was also registered to the CT angiogram and multiple
measurements were performed on the CTA studies on an Ad-
vantage Windows workstation, version 4.5 (GE Healthcare)
from this location (Figs. 4 and 5):
(1) Distance of the CVS to the closest coronary artery
(Fig. 4a) when the ablation catheter is at the SOO.
(2) Distance of the SOO to the closest site of the visceral
pericardial surface (Fig. 4b).
(3) Distance of the SOO to the left ventricular endocardium
(Fig. 4c).
Figure 4. (a-d) Show the distance of the
adjacent anatomic structures at the site of
origin: the great cardiac vein (GCV), the
left ventricle (LV), the circumflex coro-
nary artery (Cx), and the pericardial
membrane (PM) are indicated. The dis-
tance from the GCV to the closest coro-
nary artery (a) was measured when the
catheter was at the site of origin (white
asterisk). The distance is 1.0 mm to the
circumflex artery (11 o’clock). The dis-
tance from the site of origin of the ventric-
ular arrhythmia to the pericardial mem-
brane (b) was 13.7 mm and the distance
to the closest endocardial site (c) was 5.2
mm. Finally, the distance of the GCV to
the sit of origin was 1.4 mm (d). The ab-
lation procedure in this patient was suc-
cessful from the GCV. For a high quality,
full color version of this figure, please see
Journal of Cardiovascular Electrophysi-
ology’s website: www.wileyonlinelibrary.
com/journal/jce
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Figure 5. Multiplanar oblique reformat of the CTA shows the great cardiac
vein (GCV), the left ventricle (LV), and the left aortic cusps (L Cusp). The
distance from the site of origin (asterisk) to the aortic cusp was measured
(yellow line) and was 12.4 mm. For a high quality, full color version of this
figure, please see Journal of Cardiovascular Electrophysiology’s website:
www.wileyonlinelibrary.com/journal/jce
(4) Distance of the CVS to the SOO (Fig. 4d).
(5) Distance of the SOO to the aortic cusp (Fig. 5).
Finally, the distance of the CVS along the great cardiac
vein (GCV)—including the distal part of the GCV and the
beginning of the anterior interventricular vein (AIV)—to sur-
rounding anatomic structures (coronary artery, visceral peri-
cardium, left ventricular epicardium, left ventricular endo-
cardium, and aortic cusp) was measured (Fig. S1, Table S1)
in 5 mm increments. The measurements were started from
the left main coronary bifurcation by 5 mm decrements up
to 3 cm in the direction of the coronary sinus and also in 5
mm increments from the left main bifurcation up to 3 cm
into the direction of the AIV. The same measurements were
made for the middle cardiac vein starting from its origin at
the coronary sinus (Table S2).
The analysis was performed by 2 investigators (TC and
ES) who were blinded to the procedure details. Interobserver
agreement for the measured distances with an accuracy of
0.5 mm showed a kappa value of 0.88. Using commercially
available software packages (AW Volumeshare 4, General
Electric), images were analyzed in both 2D and 3D planes.
The GCV was processed from the os of the coronary sinus
to the distal aspect of the (Fig. S1).
Statistical Analysis
Categorical variables were compared using the chi-square
or Fisher’s exact test, as appropriate. If a cell size was<5, the
Fisher’s exact test was used. Normally distributed continu-
ous variables were reported as mean and standard deviation.
Multiple comparisons of categorical data were reported with
the Bonferroni correction. A P-value <0.05 was considered
significant.
Follow-Up
Patients were followed at an outpatient clinic 3 months af-
ter ablation and thereafter every 12–48 months. Holter mon-
itor was performed at 3 months postablation to assess the
TABLE 1
Patient Characteristics
Age (years) 51 ± 14
Gender (m/f) 12/5
Arrhythmia (n; PVC/VT) 8/9
Ejection fraction (%) 46 ± 12
Failed antiarrhythmic medications (n) 1.4 ± 1
Prior failed ablation procedure 12/17






PVC = premature ventricular complex; VT = ventricular tachycardia; VA
= ventricular arrhythmia; LBBIA = left bundle branch block inferior axis
morphology; LBBSA= left bundle branch block superior axis morphology;
RBBIA = right bundle branch block inferior axis morphology; RBBSA =
right bundle branch block superior axis morphology.
PVC burden. Antiarrhythmic medications were discontinued
in all patients with effective ablation procedures.
Results
Acute Ablation Outcome and Mapping Data
The ablation procedure was successful in 12/17 patients
(71%). The mean activation time at the SOO was -30 ±
9 milliseconds. The ejection fraction postablation improved
from 46 ± 12% to 54 ± 10% (P = 0.01). Successful target
sites were in the CVS alone in 3 cases, in the CVS and at
the left ventricular endocardium in 5 cases, in the CVS and
the aortic cusp in 1 case, the CVS and at the aortic cusp and
the left ventricular endocardium in 1 case, the CVS and the
endocardium and the pericardial space in 1 case, and at the
left ventricular endocardium alone in 1 case. In the remaining
4/5 cases, mapping was performed in the pericardial space.
In 1/5 patients, the pericardial space could not be accessed.
In the remaining 4 patients, pericardial mapping failed to
identify a successful target site. In these patients, the CVS,
the aortic cusps, the left ventricular endocardium, and the
right ventricular outflow tract were mapped; in 2/5 patients,
radiofrequency energy was also delivered in the right ventric-
ular outflow tract. Table 2 displays the different steps and the
ablation outcome of each step. Table 2 displays the mapping
and ablation data. When patients with successful ablations
were compared to patients with failed ablations, the activa-
tion time at the SOO was similar in these patients (29± 3 vs.
34 ± 9 milliseconds, respectively; P = 0.09). However, the
distance of the SOO to the second earliest anatomic structure
was significantly smaller in patients with successful ablations
compared to patients with unsuccessful ablations (7.4 ± 2.5
vs. 14.8 ± 2.2 mm; P = 0.0001).
SOO and Proximity to Coronary Arteries
In 10/17 patients, the SOO was estimated to be<4 mm to
the closest coronary arteries and radiofrequency energy could
not be delivered at the SOO. In 1 patient, in whom the SOO
was in the middle cardiac vein, the vein was too close to the
coronary artery along its entire course; only an endocardial
ablation was performed that resulted in elimination of the
VA. Withdrawal of the ablation catheter to a safe distance
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TABLE 2
Characteristics of Mapping and Ablation Data of the Study Patients
PVC LAT CVS LAT Adjacent Distance RF Successful RF
Patient Morphol (milliseconds) Site (milliseconds) (mm) Delivered Acute/Chronic Total (min)
1 RBIA −30 −24 5.9 (LV endo) CVS+Endo+cusp Yes/yes 16
2 RBIA −40 −18 14.4 (LV endo) CVS+Endo+Epic No/no 24
3 LBIA −35 −21 15.6 (LV endo) CVS+Endo No/no 32
4 LBIA −30 −17 7.6 (LV endo) CVS+Endo Yes/yes 10.5
5 RBIA −25 −21 10 (LV endo) CVS+Endo Yes/yes 14
6 RBIA −35 −32 17.6 (RVOT) CVS+Endo+Epic No/no 21
7 RBIA −22 NA 15 (LV endo) CVS+Endo No/no 8
8 LBIA −30 NA NA CVS Yes/yes 6
9 LBSA −27 −26 3.6 (LV endo) Endo Yes/yes 16
10 LBSA −27 NA NA CVS Yes/yes 11
11 RBIA −30 NA NA CVS Yes/yes 7
12 RBBIA −25 −17 6.4 (LV endo) CVS+Endo Yes/yes 15
13 RBIA −21 −19 7.5 (LV endo) CVS+Endo Yes/yes 14
14 RBIA −30 −22 11.6 (LV endo) CVS+Endo Yes/yes 10
15 RBIA −30 −23 11.5 (RVOT) CVS+Endo No/no 34
16 LBIA −31 −28 5 (cusp) CVS+Cusp Yes/yes 14
17 RBIA −26 −21 9.1 (LV epi) CVS+Epic Yes/yes 35
CVS = coronary venous system; Epic = epicardial; LAT= local activation time; LBIA = left bundle branch block inferior axis; LBSA = left bundle branch
block superior axis; LV endo = left ventricular endocardium; LV epi = left ventricular epicardium; RBIA = right bundle branch block inferior axis; RF =
radiofrequency energy; RVOT = right ventricular outflow tract.
from the coronary arteries was performed in the remaining
9/10 patients, and radiofrequency energy was delivered at this
location. Additional radiofrequency ablation was performed
at adjacent anatomic structures and eliminated the targeted
VA in 5/10 patients. In the remaining 4 patients, the ablation
procedure failed.
Epicardial Mapping and Ablation Within the Pericardial
Space via Subxyphoid Approach
This was attempted in 6/17 patients. In 1/6 patients, peri-
cardial access could not be obtained. The earliest timing of
the mapping procedure within the pericardial space was -
35.5 ± 7 milliseconds and was no different from the earliest
timing within the CVS (-35 ± 0.8; P = 0.9). This approach
was effective in eliminating the targeted PVC in only 1/6
patients. In this patient, the SOO was located 8.1 mm from
the visceral pericardium and 6.6 mm from the left ventric-
ular endocardium. The CVS was 4.3 mm from the SOO.
Radiofrequency energy was delivered from the CVS, the left
ventricular endocardium, and the pericardial space. Among
the patients with a failed subxyphoid epicardial approach,
the SOO was located 11.2 ± 5.5 mm from the visceral peri-
cardium and 8.9 mm from the left ventricular endocardium.
SOO and Distance to Surrounding Anatomic Structures
The closest distance of the SOO to any anatomic structure
where an ablation catheter could be positioned was the CVS,
which was at a mean distance of 2.1 mm from the SOO (the
epicardial myocardium); the second closest site to the SOO
was the left ventricular endocardium (mean of 7.7 ± 2.7
mm), followed by the visceral pericardium (mean 9.7 ± 3.7
mm). The aortic valve was furthest away from the SOO of
all the measured sites (mean 15.7 ± 5.9 mm). The CVS was
at a significantly shorter distance from the SOO than either
left ventricular endocardium or left ventricular epicardium
or aortic cusp (paired comparisons; each P < 0.0001).
In 2 patients, mapping was performed within the middle
cardiac vein. In these 2 patients, the distance between the
CVS and the epicardial myocardium at the SOO was 1 and
3.1 mm, whereas the distance to the visceral pericardium
and the epicardial myocardium at the SOO was 6.4 and 8.7
mm. The distance of the catheter location at the SOO to
the coronary artery was 0.2 and 1.5 mm and an endocardial
ablation was carried out effectively in 1 patient.
Anatomic Relations Between Adjacent Structures Along
the Course of the CVS (Tables S1 and S2)
The mean distance of the CVS to the epicardial my-
ocardium was 3.1± 1.2 mm along the course of the CVS with
a range of 2 to 6 mm. The mean distance of the epicardial sur-
face of the myocardium to the left ventricular endocardium
was 8.4 ± 2.7 mm, with a range of 4.2–11.2 mm. The dis-
tance between the epicardial and endocardial myocardium
along the proximal GCV up to the bifurcation of the left
main coronary artery was significantly shorter compared to
the distal segment along the AIV (6.4 ± 4.3 vs. 10.6 ± 0.4
mm, P < 0.001).
CVS and Proximity to Coronary Arteries
At the SOO, the CVS was at a distance of 1.5 ± 2 mm
from the closest coronary artery. The coronary arteries were
in close proximity to the CVS (mean distance of 3.3 ± 2.6
mm, range 1.1 to 10.3 mm) except near the bifurcation of
the left main coronary artery. At the level of the bifurcation,
the mean distance was 10.3 ± 8 mm; at 5 mm distal to the
bifurcation, the mean distance to the closest coronary artery
was 5.9 ± 4.2 mm; at 5 mm proximal to the bifurcation, the
closest coronary artery to the CVS was at a distance of 5.5
± 6.3 mm.
ECG Characteristics
All VAs with an origin within the GCV/AIV had an infe-
rior axis and a left bundle branch block or right bundle branch
block morphology depending on the origin within the GCV.
ECG characteristics were different depending on whether the
SOO was at the level of the bifurcation of the left main coro-
nary artery and beyond compared to a location within the
more proximal GCV. All patients with an origin within the
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middle cardiac vein had a left bundle branch block, superior
axis morphology. Analyzed parameters did not correlate with
procedural failure or success (Table S3).
Delivery of Radiofrequency Energy
In 3 patients, there was an impedance >200 Ohms and
with delivery of radiofrequency energy, the temperature mea-
sured at the catheter tip immediately rose to>50 ºC, resulting
in termination of radiofrequency energy delivery. In the first
2 cases, a cryocatheter was used to deliver cryoenergy at the
SOO and this resulted in elimination of the targeted arrhyth-
mia in 1 case and in the second case, radiofrequency energy
from the endocardium resulted in elimination of the patients’
arrhythmia. In 3 patients, radiofrequency energy was deliv-
ered at the SOO within the CVS with up to 30 W. During
ablation, however, there was no decrease of impedance and
the ablation failed to eliminate the VA. In 2/3 patients, the
VA was eliminated by radiofrequency energy delivery from
adjacent structures.
A total mean of 22± 14 minutes of radiofrequency energy
was delivered. In 6/17 patients, multiple VAs were targeted;
the ablation time for only the epicardial arrhythmias was 17
± 9 minutes. The RF time tended to be less if the arrhythmia
could be ablated within the CVS compared to arrhythmias
requiring ablation from multiple sites (8 ± 3 vs. 18 ± 9
minutes; P = 0.07). The mean procedure duration was 377
± 134 minutes.
Follow-Up
No procedural complications occurred. The PVC burden
was reduced from 28 ± 9% to 2.8 ± 4.4% at 3 months (P <
0.0001).
Discussion
Anatomic Correlations at the SOO
Proximity to the epicardial SOO is key in eliminating
VAs originating from this location. The CVS is embedded in
the epicardial fat and is closer to the epicardial myocardium
where arrhythmias arise than the visceral surface of the peri-
cardium that covers the epicardial fat. This may explain why
an epicardial ablation in the pericardial space was effective
in only 1/6 patients in whom it was attempted. This approach
failed when the epicardial fat was >10 mm from the SOO.
A prior study5 also reported a lower success rate for ablation
of idiopathic VAs using a subxyphoid pericardial approach.6
These results indicate that a subxyphoid pericardial approach
should not be used as the initial approach for idiopathic VAs
and should be reserved for cases in which other target sites
including the CVS are ineffective.
Proximity to the SOO is not the only factor important for
successful ablation of these arrhythmias. This study high-
lights other anatomic factors that play a role in the outcome
of the procedure. The location of the coronary arteries along
the course of the GCV limited access to the SOO of the VA
in more than half of the patients and necessitated catheter
withdrawal and delivery of radiofrequency energy at other
sites. This resulted in an increase in the amount of radiofre-
quency energy that was delivered in order to reach the SOO.
The proximity of the SOO to the coronary arteries rather than
imprecise mapping was the most frequent cause of failed ab-
lation in this study. If, however, the SOO was within 1 cm
of an adjacent structure where radiofrequency energy could
be delivered, this usually resulted in successful ablation in
most instances. If this was not the case, ablation was often
unsuccessful.
A pace-map with10/12 matching leads was used as evi-
dence that the ablation catheter was in contact with the SOO.
Ideally, a perfect pace-match should be present at the SOO;
however, most often high output is required for ventricular
capture within the CVS, and this can result in a larger amount
of tissue that is captured. Therefore, we used a pace-map
score of 10/12 matching leads rather than 12/12 matching
pace-maps.
Measurements along the GCV indicate that the longest
distance to the coronary arteries from within the GCV is
within 1 cm of the bifurcation of the left main coronary artery.
The proximity to the aortic valve is closest at 1 cm prox-
imal to the left main bifurcation, suggesting that in some
patients in whom an epicardial arrhythmia originates from
this area, an approach through the left aortic cusp may help
to target such a focus.
The distance of the epicardial myocardium to the endo-
cardium was shorter along the basal–lateral left ventricle as
compared to the anterior free wall, and it was a mean of 6.4
mm up to the bifurcation of the left main coronary artery.
Therefore, epicardial arrhythmias that arise from the basal–
lateral left ventricular epicardium also can be reached from
within the left ventricular endocardium; the more lateral, the
smaller the distance between the ventricular epicardium and
endocardium.
Because of the close proximity of the SOO to a coronary
artery in 4 patients, the short distance of the SOO to the
left ventricular endocardium allowed for safe applications of
radiofrequency energy at these sites to reach the SOO. This
was only possible because of the close anatomic relationship
that the SOO had with these structures.
The tapering diameter of the CVS may be responsible
for the inability to deliver sufficient radiofrequency energy
to the SOO in the distal part of the GCV or the AIV. This
may result in a high impedance or a rapid rise in temperature
during radiofrequency energy delivery despite the use of an
irrigated-tip catheter. The diameter of the open-tip irrigated
catheter is 2.5–2.7 mm, which approximates the diameter of
the distal CVS. A lack of surrounding blood flow renders
delivery of radiofrequency energy difficult even when open
irrigation is used. Cryoablation or positioning the catheter
in an anatomic structure adjacent to the SOO can help to
address this problem.
In order to better use the proximity of the CVS to the epi-
cardial myocardium for effective ablation, current catheter
technology needs to be improved. Specifically, catheter flex-
ibility needs to be improved to reach more distal sites. A
preprocedural CT angiogram may be beneficial in order to
better plan an ablation procedure in patients with epicardial
VAs.
The ECG was helpful to indicate the relative location of
the SOO in the GCV but failed to indicate patients with
unsuccessful procedures.
Middle Cardiac Vein and Surrounding Structures
The data obtained for the middle cardiac vein essen-
tially reflect the measurements along the GCV and the AIV.
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Especially, the distance from the visceral pericardium to the
underlying epicardial myocardium is in the 1.5 cm range in
the proximal part of the middle cardiac vein, whereas the
distance form the CVS to the myocardium is in the 2–4 mm
range. On the other hand, the proximity to the coronary ar-
teries can be within 1–3 mm along most of the course of the
middle cardiac vein.
Prior Publications
Yokokawa et al. as well as Abularch et al. demonstrated
the need for endocardial ablations or ablations form the aor-
tic cusps to target idiopathic, epicardial VAs.3,7 This study
extends the findings of these prior reports by correlating
anatomic structures and landmarks with electrophysiologic
findings during ablation procedures of these VAs.
Limitations
The procedure was unsuccessful in 5/17 patients and it is
possible that the SOO was not correctly identified in these
patients. However, only patients with early activation times
in whom matching pace-maps within the CVS or the epi-
cardium could be identified were included in this analysis.
Intramural origins were less likely since matching pace-maps
were obtained from the CVS.
Clinical Implications
Idiopathic VAs originating from the left ventricular epi-
cardium should be approached predominantly from the CVS
or adjacent structures including the left ventricular endo-
cardium or the aortic cusps. A subxyphoid pericardial ap-
proach most often fails due to epicardial fat separating the
ablation catheter from the epicardial myocardium. A CT
angiogram of the coronary arteries can help to assess the
anatomical relationship of the CVS to adjacent structures,
thereby facilitating the ablation procedure.
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Supporting Information
Additional supporting information may be found in the
online version of this article at the publisher’s website:
Table S1: Serial Measurements of Adjacent Anatomic
Structures Along the Great Cardiac Vein.
Table S2: Serial Measurements of Adjacent Anatomic
Structures Along the Middle Cardiac Vein.
Fig S1: Volume rendered 3-D reconstruction of the CTA
with the registered catheter electrodes within the great car-
diac vein close to the left main bifurcation (LM bifurcation).
Fig S2: Schema indicating the step-wise approach per-
formed in mapping and ablation of the patients ventricular
arrhythmias as well as the results of each step. CVS = coro-
nary venous system; VA = ventricular arrhythmias; RF =
radiofrequency energy; LV = left ventricular.
